Back to top
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Textron Inc. (TXT) - free report >>
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Textron Inc. (TXT) - free report >>
Image: Shutterstock
Best Value Stocks to Buy for February 24th
Here are three stocks with buy rank and strong value characteristics for investors to consider today, February 24th:
Deutsche Telekom AG (DTEGY - Free Report) : This integrated telecommunication services company carries a Zacks Rank #1, and has witnessed the Zacks Consensus Estimate for its current year earnings increasing 2.8% over the last 60 days.
Deutsche Telekom AG Price and Consensus
Deutsche Telekom AG price-consensus-chart | Deutsche Telekom AG Quote
Deutsche Telekom has a price-to-earnings ratio (P/E) of 11.94, compared with 17.95 for the S&P 500. The company possesses a Value Score of A.
Deutsche Telekom AG PE Ratio (TTM)
Deutsche Telekom AG pe-ratio-ttm | Deutsche Telekom AG Quote
Textron Inc. (TXT - Free Report) : This company that operates in the aircraft, defense, industrial, and finance businesses carries a Zacks Rank #1, and has witnessed the Zacks Consensus Estimate for its current year earnings increasing 10.2% over the last 60 days.
Textron Inc. Price and Consensus
Textron Inc. price-consensus-chart | Textron Inc. Quote
Textron has a price-to-earnings ratio (P/E) of 15.10, compared with 19.00 for the S&P 500. The company possesses a Value Score of B.
Textron Inc. PE Ratio (TTM)
Textron Inc. pe-ratio-ttm | Textron Inc. Quote
Embecta Corp. (EMBC - Free Report) : This medical device company carries a Zacks Rank #1, and has witnessed the Zacks Consensus Estimate for its current year earnings increasing 22.6% over the last 60 days.
Embecta Corp. Price and Consensus
Embecta Corp. price-consensus-chart | Embecta Corp. Quote
Embecta has a price-to-earnings ratio (P/E) of 13.57, compared with 19.00 for the S&P 500. The company possesses a Value Score of B.
Embecta Corp. PE Ratio (TTM)
Embecta Corp. pe-ratio-ttm | Embecta Corp. Quote
See the full list of top ranked stocks here.
Learn more about the Value score and how it is calculated here.